Bone material dispensing system and methods of use

ABSTRACT

A bone material dispensing system is provided. The bone material dispensing system comprises a funnel having a proximal portion, the proximal portion comprising a top end and a bottom end, the top end opposite the bottom end, the top end comprising a surface having a protrusion configured to receive a locking member of a bone material dispensing device and the bottom end comprising a connector configured to secure the funnel to the bone material dispensing device. A bone material dispensing system comprises a pusher and a holder is provided. A method of dispensing bone material with the bone material dispensing system is also provided.

BACKGROUND

Various devices and methods have been used to administer bone material,such as bone graft, to a surgical site. Bone graft is important inorthopedic procedures for the repair of bone defects caused by injury,disease, wounds, or surgery. Toward this end, a number of materials havebeen used or proposed for use in the repair of bone defects. Thebiological, physical, and mechanical properties of the materials areamong the major factors influencing their suitability and performance invarious orthopedic applications.

Conventionally, bone tissue regeneration is achieved by filling a bonedefect with a bone material, for example, a bone graft. Over time, thebone graft is incorporated by the host and new bone remodels the bonegraft. Bone material can include bone from the patient's own body,synthetic bone material, natural substitute bone material orcombinations thereof.

To deliver the bone material to the bone defect, oftentimes the bonematerial is mixed with liquid or a therapeutic agent, powder, fiber orgranular material. Further, transfer of bone material to the dispensingdevice is often done by crude and messy packing of the bone dispensingdevice which can cause unwanted waste and spillage of bone material.During transfer and delivery of the bone material, these devices canalso increase the risk of contamination of the bone material.Additionally, some dispensing devices can cause damage to surroundingtissue of a surgical site during administration of the bone material.Moreover, bone material can clog certain dispensing devices due to itsconsistency and/or due to the design of the dispensing device and theamount of bone material cannot be controlled effectively when thisoccurs. Some dispensing devices have a bulky surface for dispensing thebone material. However, this bulky surface may make it more difficult tomaneuver the device and more accurately dispense the bone material.

It would therefore be desirable to provide a bone material dispensingsystem that includes a reusable bone material dispensing device thatallows easier loading of the bone material, which reduces the risk ofcontamination and spillage of bone material from the dispensing device.It would be beneficial to provide a dispensing device and a funnel thatreduce clogging during dispensing of the bone material and are also ableto deliver the bone material incrementally in controlled amounts to abone defect. It would be also beneficial to provide a dispensing devicethat has a light frame, a slim profile, and the ability to accuratelydispense bone material so as to reduce wastage of the bone material. Itwould also be useful to provide a dispensing system including a kithaving a pusher and a holder for the funnel to retrieve or dispense bonematerial from the clogged funnel during or after dispensing of the bonematerial.

SUMMARY

A funnel that reduces clogging during dispensing of bone material isprovided. The funnel is able to deliver the bone material incrementallyin controlled amounts to a bone defect. In some embodiments, a pusher isprovided to allow dispensing and/or recovery of clogged or undispensedbone material that remains in the funnel. In some embodiments, a holderis provided to facilitate a stable platform to support the funnel, thedispensing system can also have a pusher to dispense the bone materialfrom the funnel.

In some embodiments, there is a bone material dispensing systemcomprising a funnel having a proximal portion, the proximal portioncomprising a top end and a bottom end, the top end opposite the bottomend, the top end comprising a surface having a protrusion configured toreceive a locking member of a bone material dispensing device and thebottom end comprising a connector configured to secure the funnel to thebone material dispensing device.

In some embodiments, there is a bone material dispensing systemcomprising a funnel having a proximal portion, the proximal portioncomprising a top end and a bottom end, the top end opposite the bottomend, the top end comprising a surface having a protrusion configured toreceive a locking member of a bone material dispensing device and thebottom end comprising a connector configured to secure the funnel to thebone material dispensing device; a pusher having a shaft and a head, theshaft having a diameter smaller than a diameter of the funnel body atleast a portion of the pusher configured to slidably move within thefunnel; and a holder configured to receive the proximal portion of thefunnel.

In some embodiments, there is a method of dispensing a bone material,the method comprising loading bone material into a bone materialdispensing system, the bone material dispensing system comprising afunnel having a proximal portion, the proximal portion comprising a topend and a bottom end, the top end opposite the bottom end, the top endcomprising a surface having a protrusion configured to receive a lockingmember of a bone material dispensing device and the bottom endcomprising a connector configured to secure the funnel to the bonematerial dispensing device.

In some embodiments, there is a method of dispensing a bone materialprovided. The method comprises loading a bone material dispensing devicewith the bone material, the bone material dispensing device comprising ahousing having a frame comprising an opening configured to slidablyreceive at least a portion of a plunger, a locking member pivotablyconnected to the housing, the locking member comprising a lockingsurface extending adjacent to the housing configured to engage a surfaceof a funnel, the frame comprising a contact surface and a front openingconfigured to engage a funnel, engaging a connector of the funnel withthe front opening of the frame and the locking member being movable in alocking position, such as a downward position to lock the surface of thefunnel to the housing, the surface having a protrusion stabilizing thelocking member, aligning the funnel with the frame and the funnelconfigured to receive at least a portion of the plunger to dispense thebone material.

While multiple embodiments are disclosed, still other embodiments of thepresent disclosure will become apparent to those skilled in the art fromthe following detailed description. As will be apparent, the disclosureis capable of modifications in various obvious aspects, all withoutdeparting from the spirit and scope of the present disclosure.Accordingly, the detailed description is to be regarded as illustrativein nature and not restrictive.

BRIEF DESCRIPTION OF THE FIGURES

In part, other aspects, features, benefits and advantages of theembodiments will be apparent with regard to the following description,appended claims and accompanying figures.

FIG. 1 is a perspective view of a bone material dispensing systemaccording to an aspect of the present application. The bone materialdispensing system comprises a bone material dispensing device, a funnel,a folding cannula, a holder and a pusher. The holder is engageable withthe funnel for retrieving/dispensing the bone material from the funnelusing the pusher.

FIG. 2 is a perspective view of the bone material dispensing deviceaccording to an aspect of the present application. The bone materialdispensing device includes a housing having a proximal end having afirst opening, a distal end having a second opening, and a longitudinalaxis. The first opening and the second opening are configured toslidably receive at least a portion of a plunger. The bone materialdispensing device includes an optional locking member that is pivotablyconnected to an upper surface of the housing and extends transverselyabove the upper surface from at least the proximal end to the distal endof the housing. The locking member comprises a distal end configured toengage a portion of a funnel.

FIG. 3 is a front view of the bone material dispensing device of FIG. 1. The bone material dispensing device includes a longitudinal axisextending in a direction from a top end toward a distal end of a contactsurface. The bone material dispending device includes a horizontal axisextending in a direction from a first edge to a second edge of thecontact surface.

FIG. 4 is a front view without the locking member of the bone materialdispensing device of FIG. 1 . The bone material dispensing deviceincludes a length extending from a top end to a distal end of a contactsurface. The bone material dispensing device includes a width extendingfrom a first edge to a second edge of a contact surface.

FIG. 5 is a perspective view of the bone material dispensing device ofFIG. 2 . The funnel and folding cannula are shown separated from thedevice.

FIG. 6 is an enlarged perspective view of a portion of the bone materialdispensing device of FIG. 2 with the housing, locking member shown inthe release position, also shown are second and third biasing membersand plunger.

FIG. 7 is an enlarged perspective view of a portion of the bone materialdispensing device of FIG. 2 with the housing, locking member shown inthe locked position, also shown are second and third biasing members andplunger.

FIG. 8 is a perspective view of the funnel of FIG. 1 .

FIG. 9 is a side view of the funnel of FIG. 1 .

FIG. 10 is a front view of the funnel of FIG. 1 .

FIG. 11 is an assembled view of the funnel, the holder and the pusher ofFIG. 1 . A pusher is inserted into the funnel's distal portion and thefunnel's proximal portion is sitting on a contact surface of the holder.

FIG. 12 is a side view of the pusher in FIG. 1 . The pusher includes ahead, a shaft and a longitudinal axis extending from a proximal portionto a distal portion of the pusher.

FIG. 13 is a side view of a dissembled shaft of the pusher in FIG. 1 .

FIG. 14 is a perspective view of a dissembled head of the pusher in FIG.1 .

FIG. 15 is a perspective view of the holder in FIG. 1 .

FIG. 16 is a bottom view of the holder in FIG. 1 .

FIG. 17 is a cross-sectional view of another embodiment the funnel. Thefunnel includes a proximal end, a funnel body, a distal end and alongitudinal axis extending from the central axis of the proximal end toa center axis of the distal end. The proximal end has an inner slopewhich forms an angle with the longitudinal axis.

FIG. 18 is a cross-sectional view of another embodiment of FIG. 12 . Thefunnel includes a tapered funnel body. The funnel body includes aproximal end having a diameter the same as the smallest diameter of theinner surface of the proximal end of the funnel. The funnel bodyincludes a distal end having a diameter larger than the diameter of theproximal end of the funnel body.

It is to be understood that the figures are not drawn to scale. Further,the relation between objects in a figure may not be to scale and may, infact, have a reverse relationship as to size. The figures are intendedto bring understanding and clarity to the structure of each objectshown, and thus, some features may be exaggerated in order to illustratea specific feature of a structure.

DETAILED DESCRIPTION Definitions

It is noted that, as used in this specification and the appended claims,the singular forms “a,” “an,” and “the,” include plural referents unlessexpressly and unequivocally limited to one referent.

The term “allograft” refers to a graft of tissue obtained from a donorof the same species as, but with a different genetic make-up from, therecipient, as a tissue transplant between two humans.

The term “autologous” refers to being derived or transferred from thesame individual's body, such as for example an autologous bone marrowtransplant.

The term “xenograft” refers to tissue or organs from an individual ofone species transplanted into or grafted onto an organism of anotherspecies, genus, or family.

The term “mammal” refers to organisms from the taxonomy class“mammalian,” including, but not limited to, humans; other primates, suchas chimpanzees, apes, orangutans and monkeys; rats, mice, cats, dogs,cows, horses, etc.

The term “patient” refers to a biological system to which a treatmentcan be administered. A biological system can include, for example, anindividual cell, a set of cells (e.g., a cell culture), an organ, or atissue. Additionally, the term “patient” can refer to animals,including, without limitation, humans.

The term “bone material” includes natural and/or inorganic material suchas, for example, inorganic ceramic and/or bone substitute material. Thebone material can also include natural bone material such as, forexample, bone which is cortical, cancellous or cortico-cancellous ofautogenous, allogenic, xenogenic, or transgenic origin. In someembodiments, bone material can include demineralized bone material suchas, for example, substantially demineralized bone material, partiallydemineralized bone material, or fully demineralized bone material.

“Demineralized” as used herein, refers to any material generated byremoving mineral material from tissue, e.g., bone tissue. In certainembodiments, the demineralized compositions described herein includepreparations containing less than 5% calcium and preferably less than 1%calcium by weight. Partially demineralized bone (e.g., preparations withgreater than 5% calcium by weight but containing less than 100% of theoriginal starting amount of calcium) is also considered within the scopeof the application. In some embodiments, demineralized bone has lessthan 95% of its original mineral content.

In some embodiments, demineralized bone has less than 95% of itsoriginal mineral content. In some embodiments, demineralized bone hasless than 95, 94, 93, 92, 91, 90, 89, 88, 87, 86, 85, 84, 83, 82, 81,80, 79, 78, 77, 76, 75, 74, 73, 72, 71, 70, 69, 68, 67, 66, 65, 64, 63,62, 61, 60, 59, 58, 57, 56, 55, 54, 53, 52, 51, 50, 49, 48, 47, 46, 45,44, 43, 42, 41, 40, 39, 38, 37, 36, 35, 34, 33, 32, 31, 30, 29, 28, 27,26, 25, 24, 23, 22, 21, 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9,8, 7, 6 and/or 5% of its original content. In some embodiments,“demineralized” is intended to encompass such expressions as“substantially demineralized,” “superficially demineralized,” “partiallydemineralized,” “surface demineralized,” and “fully demineralized.”

“Partially demineralized” is intended to encompass “surfacedemineralized.” “Partially demineralized bone” is intended to refer topreparations with greater than 5% calcium by weight but containing lessthan 100% of the original starting amount of calcium. In someembodiments, partially demineralized comprises 5, 6, 7, 8, 9, 10, 11,12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65,66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83,84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 and/or 99% ofthe original starting amount of calcium.

In some embodiments, the demineralized bone may be surface demineralizedfrom about 1-99%. In some embodiments, the demineralized bone is 1, 2,3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22,23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40,41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58,59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76,77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94,95, 96, 97, 98 and/or 99% surface demineralized. In various embodiments,the demineralized bone may be surface demineralized from about 15-25%.In some embodiments, the demineralized bone is 15, 16, 17, 18, 19, 20,21, 22, 23, 24 and/or 25% surface demineralized.

“Superficially demineralized” as used herein, refers to bone-derivedelements possessing at least about 90 weight percent of their originalinorganic mineral content, the expression “partially demineralized” asused herein refers to bone-derived elements possessing from about 8 toabout 90 weight percent of their original inorganic mineral content andthe expression “fully demineralized” as used herein refers to bonecontaining less than 8% of its original mineral context.

“Demineralized bone matrix” as used herein, refers to any materialgenerated by removing mineral material from bone tissue. In preferredembodiments, the DBM compositions as used herein include preparationscontaining less than 5% calcium and preferably less than 1% calcium byweight.

“Biocompatible” as used herein, refers to materials that, uponadministration in vivo, do not induce undesirable long-term effects.

“Osteoconductive” as used herein, refers to the ability of anon-osteoinductive substance to serve as a suitable template orsubstance along which bone may grow.

“Osteogenic”, as used herein, refers to the ability of an agent,material, or implant to enhance or accelerate the growth of new bonetissue by one or more mechanisms such as osteogenesis, osteoconduction,and/or osteoinduction.

“Osteoinductive” as used herein, refers to the quality of being able torecruit cells from the host that have the potential to stimulate newbone formation. Any material that can induce the formation of ectopicbone in the soft tissue of an animal is considered osteoinductive. Forexample, most osteoinductive materials induce bone formation in athymicrats when assayed according to the method of Edwards et al.,“Osteoinduction of Human Demineralized Bone: Characterization in a RatModel,” Clinical Orthopaedics & Rel. Res., 357:219-228, December 1998,incorporated herein by reference.

The terms “upper”, “lower”, “top”, “bottom”, “side”, “proximal”,“distal” and so forth have been used herein merely for convenience todescribe the present invention and its parts as oriented in thedrawings. It is to be understood, however, that these terms are in noway limiting to the disclosure since the dispensing systems describedherein may obviously be disposed in different orientations when in use.

The term “removably engage” includes engagement of two or morecomponents that can be used or combined into one element via theengagement of the two or more elements with a connecting means, alocking means, or by placing the elements tightly together. The two ormore elements may be positioned adjacent to each other and each includea contacting surface.

For the purposes of this specification and appended claims, unlessotherwise indicated, all numbers expressing quantities of ingredients,percentages or proportions of materials, reaction conditions, and othernumerical values used in the specification and claims, are to beunderstood as being modified in all instances by the term “about.”Accordingly, unless indicated to the contrary, the numerical parametersset forth in the following specification and attached claims areapproximations that may vary depending upon the desired propertiessought to be obtained by the present invention. At the very least, andnot as an attempt to limit the application of the doctrine ofequivalents to the scope of the claims, each numerical parameter shouldat least be construed in light of the number of reported significantdigits and by applying ordinary rounding techniques.

Notwithstanding the numerical ranges and parameters set forth herein,the broad scope of the invention is an approximation; the numericalvalues set forth in the specific examples are reported as precisely aspossible. Any numerical value, however, inherently contains certainerrors necessarily resulting from the standard deviation found in theirrespective testing measurements. Moreover, all ranges disclosed hereinare to be understood to encompass any and all subranges subsumedtherein. For example, a range of “1 to 10” includes any and allsubranges between (and including) the minimum value of 1 and the maximumvalue of 10, that is, any and all subranges having a minimum value ofequal to or greater than 1 and a maximum value of equal to or less than10, e.g., 5.5 to 10.

Reference will now be made in detail to certain embodiments of thedisclosure, examples of which are illustrated in the accompanyingfigures. While the disclosure will be described in conjunction with theillustrated embodiments, it will be understood that they are notintended to limit the disclosure to those embodiments. On the contrary,the disclosure is intended to cover all alternatives, modifications, andequivalents that may be included within the disclosure as defined by theappended claims.

The headings below are not meant to limit the disclosure in any way;embodiments under any one heading may be used in conjunction withembodiments under any other heading.

Dispensing System

A bone material dispensing system 20, as shown in FIGS. 1-7 is providedthat includes a reusable bone material dispensing device 22 that allowseasier loading of bone material, reducing the risk of contamination andspillage of bone material from the bone material dispensing device. Thesystem also has a delivery funnel 400 that substantially encloses thebone material to ease loading the bone material into the device and easedispensing of the loaded bone material from the funnel to reduce oreliminate clogging and reduce or eliminate resistance when the bonematerial is dispensed. The system also has a cannula 165 that enclosesthe bone material allowing the bone material to be packed when loaded tothe funnel, as described herein. The system can also have a pusher 600that can be inserted into the funnel to dispense or remove the bonematerial from the funnel, as described herein. The system can also havea holder 500 that serves as a platform to hold the funnel in an uprightposition allowing the pusher to push the bone material with ease, asdescribed herein.

The reusable bone material dispensing device administers bone materialto a surgical site in incremental amounts. The bone material dispensingdevice can be a bone material dispensing device that reduces the risk ofcontamination and spillage of bone material from the dispensing deviceand administers the bone material to a surgical site (e.g., bone defect)while reducing damage to surrounding tissue. The bone materialdispensing device reduces clogging and allows incremental dispensing ofthe bone material. The bone material dispensing device is alsoconfigured for left handed and right handed use. A surgical site caninclude, but is not limited to, injury defects brought about during thecourse of surgery, infection, malignancy or developmental malformation.Specific bones which can be repaired or replaced with the bone materialcan include, but are not limited to, the ethmoid; frontal; nasal;occipital; parietal; temporal; mandible; maxilla; zygomatic; cervicalvertebra; thoracic vertebra; lumbar vertebra; sacrum; rib; sternum;clavicle; scapula; humerus; radius; ulna; carpal bones; metacarpalbones; phalanges; ilium; ischium; pubis; femur; tibia; fibula; patella;calcaneus; tarsal and metatarsal bones. In some embodiments, the bonematerial dispensing device administers bone material to at least aportion of the spinal cord such as vertebrae or a vertebra.

The bone material dispensing device includes a housing 25 having aproximal end 26, a distal end 28, and a longitudinal axis AA disposedtherebetween, as shown in FIG. 2 . The proximal end of the housingincludes a first opening 30 and the distal end includes a second opening32, as shown in FIG. 6 . The first opening and the second opening areconfigured to slidably receive at least a portion of a plunger 34, asdescribed herein. The distal end 28 of the housing comprises a distalframe body or a frame 300. The distal frame is monolithic with thehousing. The frame comprises a front wall 310, a back wall 312, a frameopening or an air gap 302. The front wall is disposed away from theproximal end of the housing and is configured to contact a funnel 176.The back wall is disposed closer to the proximal end of the housing. Theback wall comprises a back opening 308 configured to receive theplunger. The air gap is disposed between the front wall and the backwall. The air gap comprises a generally rectangular profile with alonger length along a length L of the frame, as shown in FIG. 4 . Insome embodiments, the length of the frame extends from a top end 318 toa tapered end 320 of the frame along a longitudinal axis LA. The frameprovides support to the plunger as it passes through the distal end ofthe housing while allowing the funnel to securely engage the contactsurface 306 disposed on the front wall. In some embodiments, the contactsurface has a generally flat surface comprising the second opening. Insome embodiments, the second opening is larger than the back opening. Insome embodiments, the contact surface further comprises a front opening304. The front opening is disposed below the second opening, which isdisposed adjacent to the tapered end. In some embodiments, the frontopening is configured to receive a corresponding protrusion (not shownin figures) from the funnel. In some embodiments, the funnel does notcontact and/or cover the front opening. The contact surface can be atubular shape (e.g., oval, circular, etc.) or a non-tubular shape (e.g.,rectangular, triangular, square, etc.). In some embodiments, theproximal end of the funnel is such that the funnel is only partiallycovered by the generally rectangular contact surface in the middle whenthe second opening is aligned with funnel passage 179, while otherportions of the funnel are not covered by the contact surface, as shownin FIGS. 6 and 7 . In some embodiments, the frame further comprises atop end and a tapered end opposing each other along the longitudinalaxis, as shown in FIGS. 3 and 4 . In some embodiments, the top end has aflat profile configured to match a bottom surface of a locking member46. The tapered end has a shorter width than a width W of the frame, asshown in FIG. 4 . In some embodiments, the width across the secondopening is longer than the width across the tapered end, as shown inFIG. 3 . In some embodiments, the front wall further comprises a firstedge 314 and a second edge 316. In some embodiments, the width of theframe extends from the first edge to the second edge along a horizontalaxis HA. In some embodiments, the first edge and the second edge extendfrom the top end to the tapered end. In some embodiments, the first edgeand the second edge join at the tapered end at an apex 322 of thetapered end forming a triangular shape such that the front wall has agenerally rectangular portion and a generally triangular portion. Thisconfiguration gives the device a slim profile so that the device iseasier to maneuver and handle in use.

The first opening has a diameter D1 and the second opening has adiameter D2, as shown in FIG. 7 . D1 and D2 are the same diameter. Insome embodiments, D1 and D2 can have different diameters. In someembodiments, the diameters D1 and D2 can be from about 2 millimeters(mm) to about 40 mm. The diameters can be from about 2, 4, 6, 8, 10, 12,14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm. Thefirst and second openings can be shaped and can be round, oval,rectangular or square.

The plunger, as described herein, has a proximal end 36, a distal end 38and a body 40 disposed therebetween. The plunger is configured to assistin the dispensing/administration of the bone material to a surgicalsite, as described herein. This allows for controlled and incrementaladministration of the bone material to the bone defect. The proximal endof the plunger includes a stopper 42 that is configured to prevent theplunger from passing entirely through the first and second openings ofthe housing when the plunger is translated in the direction of thedistal end of the housing. In some embodiments, the stopper can be ballshaped and have a diameter that is greater than diameters D1 and D2. Insome embodiments, the distal end of the plunger can include a tip 44having various geometries and sizes that are tailored for various sizedcannulas, as described herein, and/or for varying viscosities of bonematerial, as described herein. In some embodiments, the tip of theplunger can be square, rectangular, round, plug, or disc shaped.

The tip can have a diameter D3 and the body can have a diameter D4, asshown in FIG. 5 . In some embodiments, diameter D3 is larger thandiameter D4. In some embodiments, diameters D3 and D4 are the same size.Diameter D4 of the body of the plunger is smaller than diameters D1 andD2, and diameter D3 can be larger, the same or less than diameters D1and D2. In some embodiments, the diameter D4 of the body of the plungeris slightly smaller than diameters D1 and D2 but allows at least aportion of the plunger to slide within the openings. In someembodiments, diameters D3 and D4 can be from about 2 millimeters (mm) toabout 36 mm. The diameters D3 and D4 can be from about 2, 4, 6, 8, 10,12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34 to about 36 mm. Theplunger can also have a certain length L1 of from about 1 to about 20inches, as shown in FIG. 5 . In some embodiments, the length L1 of theplunger can be from about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,15, 16, 17, 18, 19 to about 20 inches. The plunger length can besmaller, larger or the same size as the cannula 165, as describedherein. In some embodiments, the plunger can be flexible or rigid.

The bone material dispensing device includes a locking member 46. Thelocking member is configured to lock a portion of a funnel, as describedherein, to the housing of the bone material dispensing device. Thelocking member is pivotably connected to an upper surface 48 of thehousing and extends adjacent to the upper surface of the housing, asshown in FIGS. 2, 6 and 7 . The locking member includes a proximal end50 configured to engage with a biasing member, as described herein, anda distal end 52 configured to engage with a portion of the funnel andthe top end of the frame, as described herein, and an intermediateportion 54 disposed therebetween configured to pivotably engage with aportion of the upper surface of the housing.

The locking member is movable in a locking position, such as a downwardposition, to lock the portion of the funnel with the housing, and thelocking member is movable in an unlocking position, such as an upwardposition, to unlock the portion of the funnel from the housing, asdescribed herein.

The proximal end of the locking member includes an outer surface 56 thatincludes, in some embodiments, a gripping surface 58 that provides agrip for a user when the user pushes downward on the proximal end of thelocking member during use. An interior surface 60 of the locking memberdefines a stanchion 62 disposed at the proximal end that is configuredfor engagement with a first end 66 of a first resilient member, such asa first spring 64, as shown in FIGS. 2 and 7 . A portion of the uppersurface of the proximal end of the housing includes a recess 68configured for engagement with a second end 70 of the first spring. Thestanchion and the recess are configured for engagement with the firstspring.

The intermediate portion of the locking member includes a pivot point 72engaged with the upper surface of the housing. The pivot point includesan opening 74, a pin 76 and an opening 78 formed from a portion of theupper surface of the housing, as shown in FIGS. 6 and 7 . The pin isconfigured for disposal within openings 74 and 78. In some embodiments,the pivot point pivots at an angle α1 of about 1 degree to about 30degrees. In some embodiments, the pivot point pivots at an angle α1 ofabout 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19,20, 21, 22, 23, 24, 25, 26, 27, 28, 29 to about 30 degrees.

The distal end of the locking member includes a locking surface, such asa flange 80 that extends adjacent to the distal end of the housing. Theflange locks a portion of the funnel with the housing of the bonematerial dispensing device. As shown in FIG. 6 , the flange can includean inner surface that is grooved 82 to facilitate engagement with aportion of the funnel.

The flange at the distal end of the locking member is moved in adownward position to lock the portion of the funnel with the housing, asshown by arrow BB in FIG. 7 . When the flange is in the downwardposition, the proximal end is positioned in an upward direction, asshown by arrow CC. In this configuration, the first spring is partiallycompressed with the stored energy applying constant force against bothstanchion 62 and recess 68. In some embodiments, the flange comprisesthree contacting surfaces forming n-shaped tongs to contact and securethe delivery funnel. A first contact surface 452, a second contactsurface 454 and a third contact surface 456 are shown in FIG. 7 . Theflange unlocks the funnel when the flange is moved in an upwardposition, as shown by arrow DD in FIG. 6 , when the user pushes theproximal end of the locking member in a downward direction, as shown byarrow EE. In this configuration, the first spring is further compressedand energy is stored for use when the locking member is moved again inthe downward position, as described above.

The housing includes a trigger assembly 98, as shown in FIG. 2 , that isconfigured to allow incremental slidable movement of the plunger todispense the bone material, as described herein. The trigger assemblyincludes a driving handle 100 and a stationary handle 102. The drivinghandle includes a proximal end 104, a distal end 106 and a longitudinalaxis HH disposed therebetween. The proximal end of the driving handle isconfigured for pivotable engagement with an intermediate portion of thestationary handle and a proximal end of a driving pawl, as describedbelow. The proximal end of the driving handle includes a cavity 108, asshown in FIGS. 2 and 4 . The cavity is configured for movable engagementwith a portion of the driving pawl, as described herein.

The proximal end of the driving handle and transverse to the cavityincludes a recess 110. The recess is configured for engagement with apin 112 such that the proximal end of the driving handle pivotablyengages with a portion of the driving pawl, as described herein. Theproximal end of the driving handle includes a recess 114, as shown inFIG. 2 . The recess is configured for engagement with a pin 116 suchthat the proximal end of the driving handle is movably engaged with aportion of the housing. The housing includes a recess 118 configured toengage with pin 116.

A surface of the driving handle includes gripping surfaces 119. Thegripping surfaces are configured for engagement with a user's hand suchthat the driving handle can be controlled effectively by the user. Thegripping surfaces can be raised, curved or straight. The grippingsurfaces can also be roughened to increase the control that the user hasover the driving handle.

The user moves the driving handle in the direction of the stationaryhandle. The driving handle engages the active pawl, which slides theplunger longitudinally and incrementally in the direction of the distalend. This allows for bone material to be incrementally dispensed fromthe bone material dispensing device.

The stationary handle includes a proximal end 120, a distal end 122, anintermediate portion 124 and a longitudinal axis II disposed between theproximal end and the distal end. The proximal end of the stationaryhandle includes a first side 126, a second side 128 and a third side130, as shown in FIGS. 6 and 9 . The first, second and third sides arepart of the housing. The proximal end of the stationary handle can bemonolithic with the housing and the first, second and third sides can bemonolithic or fixed to the stationary handle. The intermediate portionof the stationary handle can be monolithic with the housing, and theintermediate portion can be inserted into the cavity of the drivinghandle. The second side includes a slot 132 that is configured forengagement with a portion of a passive pawl, as described herein andshown in FIG. 4 . In some embodiments, the stationary handle and thehousing are monolithic with one another. In some embodiments, thestationary handle and the housing are not monolithic.

The intermediate portion of the stationary handle is configured forengagement with the proximal end of the driving handle. The drivinghandle pivots towards and away from the stationary handle at an angle α3from about 1 to about 60 degrees, shown in FIG. 2 . In some embodiments,α3 is from about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16,17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34,35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52,53, 54, 55, 56, 57, 58, 59 to about 60 degrees.

The stationary handle defines one or more cutouts 134, as shown in FIG.7 . The cutouts can be oval, round, square, triangular, rectangular orany other regular or irregular shape. There can be one or more cutoutsformed from the surface of the stationary handle, such as 1, 2, 3, 4, 5,6 or more cutouts.

The trigger assembly of the housing further includes a driving pawl 136and a passive pawl 138, as shown in FIGS. 6 and 7 . The driving pawl isconfigured to work in conjunction with a resilient member to assist thestationary handle and the driving handle in incremental slidablemovement of the plunger such that the plunger dispenses the bonematerial. In the embodiment shown in FIG. 6 , the resilient member shownas a spring is concentric with the plunger. On movement of the drivinghandle to the stationary handle, pawl 136 engages plunger 34 and pushesthe plunger longitudinally in increments while simultaneouslycompressing the spring. The driving pawl is disposed at one end of theresilient member and the other end of the resilient member is biasedagainst the housing and plunger. Once the driving handle is released,the stored energy in the spring returns the driving handle and pawllongitudinally to their original positions.

The driving pawl includes a first end 140 and a second end 142, as shownin FIG. 4 . The first end of the driving pawl is configured for movableengagement within the cavity of the driving handle. Recess 110 and arecess 144 disposed within the first end of the driving pawl, engagewith pin 112 such that the proximal end of the driving handle pivotableengages with the first end of the driving pawl. The driving pawlincludes a third opening 146 that is in alignment and in between thefirst opening and the second opening of the housing, as shown in FIGS. 3and 4 . The third opening is configured to slidably receive at least aportion of the plunger, as described herein. The third opening can becentrally located on the driving pawl.

The third opening has a diameter D5, as shown in FIG. 7 . D5 can be thesame diameter as D1 and D2, and D5 has a greater diameter than plungerdiameter D4. In some embodiments, D5 can have a different diameter thanD1 and D2. In some embodiments, diameter D5 can be from about 6millimeters (mm) to about 40 mm. Diameter D5 can be from about 6, 8, 10,12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm.The third opening can be shaped and can be round, oval, rectangular orsquare.

The passive pawl includes a first end 148 and a second end 150, as shownin FIGS. 6 and 7 . The first end is configured for engagement with slot132. The passive pawl is configured to work in conjunction with aresilient member to control when the plunger is advanced duringdispensing of the bone material and retracted after dispensing orreloading of the bone material. The passive pawl allows the plunger tobe adjusted so that the plunger can be located adjacent to the bonematerial and if more bone material is added to the cannula, the plungercan be adjusted to be placed adjacent to the additional bone material.In this way, the bone material dispensing device can easily accommodatevarious quantities of bone material.

The passive pawl can pivot at an angle α4 of from about 2 to about 45degrees, as shown in FIG. 7 . In some embodiments, α4 is from about 1,2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38,40, 42, 44, 45 or from about 46 degrees.

The passive pawl includes a fourth opening 152 that is above and inalignment with the first opening and the second opening of the housing,and the third opening of the driving pawl, as shown in FIGS. 6 and 7 .The fourth opening is configured to slidably receive at least a portionof the plunger, as described herein. The fourth opening can be centrallylocated on the passive pawl.

The fourth opening has a diameter D6, as shown in FIG. 7 . D6 can be thesame diameter as D1, D2 and D5, and has a greater diameter than plungerdiameter D4. In some embodiments, D6 can have a different diameter thanD1, D2 and D5. In some embodiments, diameter D6 can be from about 6millimeters (mm) to about 40 mm. Diameter D6 can be from about 6, 8, 10,12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm.The fourth opening can be shaped and can be round, oval, rectangular orsquare.

The trigger assembly includes a second resilient member, such as asecond spring 154 as shown in FIG. 2 , that is configured for engagementwith the passive pawl and a portion of the plunger, as described herein.The second spring is disposed on a portion of the plunger and betweenthe second side 128 of the stationary handle and the passive pawl, asshown in FIGS. 2 and 6 . The second spring comprises a proximal end 156configured for engagement with an underside of the passive pawl and adistal end 158 which engages with the second side 128 of the stationaryhandle and the first opening 30 of the housing. The second spring isconcentric with the fourth opening of the passive pawl and is concentricto the plunger. On moving the passive pawl toward the stationary handle,the second spring can be compressed and store energy, which will allowthe plunger to be withdrawn or adjusted to allow bone material to beadded to the cannula.

The trigger assembly includes a third resilient member, such as thirdspring 160 that is configured for engagement with the driving pawl, asdescribed herein. The third spring is disposed concentric to the plungerand is disposed between a portion of the distal end of the housing andthe driving pawl, as shown in FIGS. 6 and 7 . The third spring comprisesa proximal end 162 that engages with a distal surface of the drivingpawl, and a distal end 164 that engages with the second opening 32 ofthe housing. At least a portion of the plunger is configured to beslidably received by the third spring, as described herein.

The folding cannula is similar to the foldable container found and fullydescribed in U.S. application Ser. No. 15/581,817, of which is owned byApplicant and incorporated fully herein by reference. The foldingcannula is configured to be loaded with the bone material and engagesthe funnel and/or the plunger for dispensing the bone material into asurgical site. The folding cannula comprises a proximal end 166 and adistal end 168. The folding cannula is segmented into an uppercompartment 170 and a lower compartment 172, and the folding cannula ismovable in a folded configuration and an unfolded configuration about afold line 174.

The folding cannula has a diameter D7 that is smaller than a diameter ofthe funnel so as to allow at least a portion of the folding cannula tobe held within the funnel, as shown in FIGS. 2 and 5 . In someembodiments, diameter D7 can be from about 2 millimeters (mm) to about40 mm. The diameter D7 can be from about 2, 4, 6, 8, 10, 12, 14, 16, 18,20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm. The foldingcannula can have differing diameters throughout the folding cannula anddoes not have to have a uniform diameter.

In some embodiments, the proximal end of the folding cannula can havevarious geometries and sizes. In some embodiments, the proximal end ofthe folding cannula can be square, rectangular, round, plug, or discshaped. The proximal end geometry of the folding cannula can have adiameter D9 that is larger than diameter D7 such that the proximal endgeometry cannot pass the second opening 32 of the distal frame. In someembodiments, the diameter D9 can be from about 6, 8, 10, 12, 14, 16, 18,20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm.

Delivery Funnel

In some embodiments, the folding cannula engages with a delivery funnel400 that is configured to removably engage the contact surface of thedispensing device, as shown in FIGS. 2, 6, 7 and 11 . The deliveryfunnel 400, as shown in FIGS. 8-10 , comprises a proximal portion 402, adistal portion 404 and a body 406. The distal portion includes a distalopening 405 and a distal tip 408. The distal tip may have variousshapes, including circular, rectangular, polygonal. In some embodiments,the distal end of the funnel has a tip geometry, for example, a tipgeometry that is indented to assist in the administration of the bonematerial to the surgical site. In some embodiments, the distal tip has aflange shape, in which the distal tip has a generally cylindricalprofile with a middle section of the cylinder being an open space. Thebody of the delivery funnel has a passageway 442 extending along theentire body along a central axis CA from the proximal portion to thedistal portion. The body has a proximal end 444, which joins theproximal portion of the funnel, and a distal end joins the distal tip ofthe funnel. The passageway allows the bone material to pass from theproximal portion through the body to the distal portion, where it isdispensed.

The proximal portion of the delivery funnel comprises a top end 410, abottom end 424, and a body 448. The top end comprises a first holdingsurface 412, a second holding surface 414 and a third holding surface416. The second holding surface is configured to receive a lockingmember of a bone material dispensing device. In some embodiments, thelocking member has three contact surfaces forming n-shaped tongs suchthat the second contact surface 454 of the locking member is a groovereceiving the second holding surface of the funnel. The holding surfaceshave a generally rectangular profile across the width PW of the proximalportion. In some embodiments, the holding surfaces have a crescent shapewith the thickest part pointing upward toward the locking member. Theholding surfaces are aligned in series with the first holding surfacecloser to the proximal direction on the central axis of the dispensingdevice. In some embodiments, the first holding surface is an outersurface of the body of the proximal portion, which defines a top surfaceof a rectangular structure of the body. In some embodiments, the secondholding surface is the only portion contacting the locking member. Thethird holding surface can be closer to the distal direction on thecentral axis while the second holding surface is in the middle. In someembodiments, the top end further comprises a guard protrusion 418disposed on the second holding surface extending in a transversedirection relative to the central axis. In some embodiments, the guardprotrusion comprises two guard protrusions disposed on two opposite endsof the second holding surface across the width of the proximal portion.The guard protrusions are configured to secure and stabilize the lockingmember once the locking member is received at the second holdingsurface. The guard protrusion stabilizes and defines the boundary of thelocking member across the width of the funnel to ensure the lockingmember does not move about on the holding surface. In some embodiments,the two guard protrusions are disposed on the second holding surface,which mimic bat-like ears. The proximal portion further comprises afirst edge 420 and a second edge 422 opposing the first edge across thewidth of the proximal portion. In some embodiments, the first holdingsurface is a top surface of a rectangular structure such that thestructure has a side surface serving as a top contact surface 438. Insome embodiments, the top contact surface is configured to contact thedispensing device or a holder 500. In another embodiment, the topcontact surface does not contact any surface leaving a gap between thetop contact surface and the dispensing device or the holder. The gapallows the top end of the funnel to be freely rotated withoutunnecessary friction when engaging the locking member. The bottom of thestructure has a bottom edge 450 defining the bottom boundary of the topend.

The bottom end of the proximal portion comprises a rectangular-likestructure and triangular-like structure. The top of the rectangular-likestructure includes a side edge 428 and a top edge 426 defining the topboundary of the bottom end. The bottom end comprises a first taperededge 430 and a second tapered edge 432 that extends toward the bottomboundary of the bottom end and joins at an apex 434 forming atriangular-like shape. The bottom end comprises a protrusion extendingtoward a proximal direction along a longitudinal direction to serve as aconnector 436 configured to secure the funnel to a dispensing device ora holder. The protrusion is configured to be inserted into acorresponding opening on the dispensing device or on the holder. Theconnector is disposed adjacent to the apex. A side of the bottom endcomprises a distal contact surface 440 configured to contact adispensing device or the holder. When the connector is inserted into thedispensing device, it serves as an anchor or a pivot point for thefunnel to rotate. When a user pushes the proximal end of the lockingmember in a downward direction, as shown by arrow EE in FIG. 6 , theflange is moved in an upward position, as shown by arrow DD in FIG. 6 .The flange of the locking member is in an unlocked position allowing thefunnel to rotate around the connector and to slide the second holdingsurface to match the second contact surface of the locking member.

The bottom edge of the top end also defines a top boundary of the bodyof the proximal portion and the top edge of the bottom end also definesa bottom boundary of the body of the proximal portion. The body includesa generally flat plane and a proximal opening 403 configured to alignwith an opening in the dispensing device and receive at least a portionof a plunger. The proximal opening has a diameter DD1, which is the sameas the widest opening of a proximal end 444 of the body of the deliveryfunnel. The proximal portion has a length PL across from the top end tothe bottom end. When the funnel is in rotation via the connector, therotation also allows the proximal opening to align with the secondopening of the dispensing device.

The passageway 442 has a diameter DD2, which is smaller than DD1. Theproximal end of the body has a generally conical shape comprising aninner surface 446 forming a slope. The dimension of the proximal end ofthe body and the proximal opening of the proximal portion are configuredto facilitate the east of removal of a cannula from the funnel by hand.The dimension and the configuration also help avoid requiring forceps topull the cannula out of the funnel. The slope and the central axis CAforms an angle α. The diameter of the proximal end has its widest partjoining the proximal opening of the proximal portion and the size of thediameter diminishes toward the diameter of the passageway. The distalend of the body of the delivery funnel joins the distal portion of thedelivery funnel at a ring of ledge 458. The ledge has a diameter DD3smaller than DD1 and DD2. The ledge serves as a stop surface for loadingthe cannula. As the plunger exerts force onto the cannula in the funnel,the bone material inside the cannula can exit through the distalopening; meanwhile, the cannula can remain inside the funnel untilremoved by the user, where in some embodiments, it can be disposed.

In some embodiments, the angle α is from about 2, 4, 6, 8, 10, 12, 14,16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50,52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86,88, to about 90 degrees. In some embodiments, angle α is about 35degrees.

In some embodiments, the funnel body is straight, having a cylindricalshape. The diameters DD1, DD2 and DD3 can be from about 2, 4, 6, 8, 10,12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm.The funnel has a length L2, which can be, for example, about 1 to about20 inches. In some embodiments, the length of the funnel can be fromabout 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19to about 20 inches. In some embodiments, the funnel and the plunger areflexible. In some embodiments, the funnel and the plunger are rigid. Insome embodiments, the plunger is more rigid that the funnel. In otherembodiments, the funnel is more rigid than the plunger.

In some embodiments, the funnel locks with a portion of the distal endof the housing via the flange of the locking member and a front openingon the contact surface. In some embodiments, the funnel comprises aprotrusion that allows mating and locking with the front opening, asdescribed above. In some embodiments, the front opening is a detent thatcan be a catch, a lever, a spring, or a hinged catch that engages anotch of a ratchet, a protrusion, wall, or a combination thereof. Thelocking will allow the openings to align (as shown in FIGS. 6 and 7 )and the plunger now can be slid through the openings. In someembodiments, the funnel can be entirely detachable and can snap onto thehousing. In some embodiments, the funnel can be pivotably connected tothe housing in a similar manner to a breech-loaded shotgun.

Dispensing Kit

The bone material dispensing system includes pusher 600, as describedabove and shown in FIGS. 1 and 11-14 . The pusher is configured forinserting into the funnel to push out the bone material. In someembodiments, the pusher is also a dispensing device configured todeliver bone material through the funnel. The pusher is configured toreceive force from a user via their hand or a tool such as a hammer. Thepusher is configured to remove and/or dispense the bone material fromthe funnel and/or cannula. The pusher is configured to insert into thefunnel from the proximal portion and/or the distal portion. In someembodiments, when the funnel is sitting on top of the holder, the pusheris inserted from the distal portion of the funnel as shown in FIG. 11 .In some embodiment, the pusher is configured to insert in to the funnelfrom the proximal portion to deliver the bone material. In someembodiments, the funnel has its proximal portion sitting on a flatsurface and the pusher is inserted through the distal end to push outthe bone material.

In some embodiments, the funnel is a funnel 176 in FIGS. 17-18 . Aproximal end or a proximal portion 178 of the funnel can be inserted todeliver the bone material. In some embodiments, the proximal portion hasa conical shape having a diameter DD1 formed by an inner surface of theproximal portion. The proximal portion has the largest diameter furthestaway from a funnel body 177 of the funnel and the smallest diameteradjacent to the funnel body. A point on the largest diameter and a pointon the smallest diameter forms a slope 175 along the inner surface ofthe proximal portion. The slope on the inner surface of the proximalportion forms an angle α with a central axis CA, which extends in thedirection of the funnel passage from the proximal portion to the distalend 180 of the funnel, as shown in FIGS. 17 and 18 .

In some embodiments, the angle α is from about 2, 4, 6, 8, 10, 12, 14,16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50,52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86,88, to about 90 degrees. In some embodiments, angle α is about 35degrees.

In some embodiments, the distal end of the funnel has a tip geometry,for example, a tip geometry that is shaped or indented to assist in theadministration of the bone material to the surgical site. In someembodiments, the funnel body is straight, having a cylindrical shapelonger than a length of the proximal end of the funnel, as shown in FIG.17 . The diameter of the funnel body is the same from diameter DD4 ofthe funnel body's proximal end to diameter DD3 of the distal end of thefunnel. FIG. 18 illustrates another embodiment of the funnel. In someembodiments, the funnel body is sloped or tapered, having a gradientwith increasing diameters toward the distal end of the funnel forming aconical shape opposing the conical shape of the proximal end. The twoopposing conical shapes having the smallest diameter DD4 jointly at aproximal end of the funnel body. The distal end has a diameter DD3,which is larger than DD4. In some embodiments, the diameter DD3 issmaller than the largest diameter of the proximal end of the funnel. Theinner surface of the funnel body has a second slope 181 formed at anangle ß with a central axis CA, which extends in the direction of thefunnel passage from the proximal end to the distal end of the funnel, asshown in FIGS. 17 and 18 . In some embodiments, the distal end of thefunnel has an inner surface having the second slope 181 forming theangle ß with a central axis CA.

In some embodiments, the distal end of the funnel comprises a ring ofledge. The ledge has a diameter DD3 smaller than DD1 and DD2. The ledgeserves as a stop surface for loading the cannula. As the plunger exertsforce onto the cannula in the funnel, the bone material inside thecannula can exit through the distal opening; meanwhile, the cannula canremain inside the funnel until removed by the user, where in someembodiments, it can be disposed.

The diameters DD1, DD3 and DD4 can be from about 2, 4, 6, 8, 10, 12, 14,16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 to about 40 mm. In someembodiments, the angle ß is from about 2, 4, 6, 8, 10, 12, 14, 16, 18,20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54,56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, toabout 90 degrees. In some embodiments, the angle ß is less the angle αand/or less than 35 degrees. The funnel has a length L2, which can be,for example, about 1 to about 20 inches. In some embodiments, the lengthof the funnel can be from about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,13, 14, 15, 16, 17, 18, 19 to about 20 inches.

The pusher includes a shaft 602 and a head 604. The pusher also has aproximal portion 608 and a distal portion 606 extending along alongitudinal axis RLA. The shaft comprises a distal end 610, andproximal end 612 and a body 620. The body has a diameter RDD1. Theproximal end of the shaft adjoins the head. The proximal end of theshaft has a ring 614 and a tip 616. The tip has a diameter RDD3 and isconfigured to fit and connect to the head such that the head enclosesthe tip completely. The ring has a diameter RDD2 and is also configuredto fit and connect to the head such that the head only partiallyencloses the ring. The shaft also has a tapered ring 618 joining thering and the shaft body. It is noted that RDD2 is greater than RDD3,which is greater than RDD1. The tapered ring has a gradually decreasingdiameter between RDD2 and RDD1, as shown in FIG. 13 . The head has 3portions including a holder ring 622 disposed closer to the distalportion on the longitudinal axis. The holder ring is configured toprovide a rest surface for a user's finger or a gripping tool. Agripping ring 626 is adjacent to the holder ring and has a diametersmaller than the holder ring. The gripping ring is configured to providestructure and to receive a load of force. A loading ring 624 is adjacentto the gripping ring and is disposed in the proximal direction. Theloading ring is configured to provide a surface for a user to exert theforce, via a head or other tool, including a hammer. In someembodiments, the loading ring has a generally flat profile. In someembodiments, the loading ring has a crescent curve which conformsergonomically to a human palm. The head further comprises an opening 628for a shaft to be inserted and securely connected to the head. Theopening of the head and the tip of the shaft may be threadedly connectedor snap-fitted. The opening has a diameter RHDD2 corresponding to thediameter of the ring of the shaft and a diameter RHDD3 corresponding tothe diameter of the tip of the shaft allowing the shaft and the head toconnect together.

The bone material dispensing system includes holder 500, as describedabove and shown in FIGS. 1 and 15-16 . The holder is configured toprovide a stabilized surface for the funnel and to withstand an impactwhen a force is exerted to push the bone material out of the funnel. Theholder is configured to have a surface, which conforms to the shape ofthe proximal portion of the funnel. The holder is configured to receivea force from a user via their hand or a tool such as a hammer.

The holder includes a support and a platform. A support includes a firstsupport 502 and a second support 504. In some embodiments, the supportsare rectangularly structured providing legs to the plane. The platformincludes a perimeter 512 defining the boundaries of the holder, acontact surface 506 configured to receive the proximal portion of thefunnel, and an island 514 protruding from the contact surface. Thecontact surface is disposed on a platform plane 520, which is adepression having a depth from a topmost point of the perimeter of theholder to the platform plane. The depression depth is configured tofurther stabilize the funnel when it sits on the contact surface. Thecontact surface also includes tapered edges and an apex matching thetapered edges and the apex of the funnel. The contact surface has afirst opening 508 configured to receive a protrusion from the funnel.The island comprises a second opening 510 configured to align with theproximal opening of the funnel. The platform has a length PL and a widthPW. The platform has a first tapered edge 516 extending along the lengthof the platform and a second tapered edge 518 opposing the first taperededge across the width. The tapered edges of the platform are taperedalong the depression depth.

In operation, the folding cannula is loaded with the bone material andinserted into the proximal end of the funnel so that at least a portionof the folding cannula is held within the funnel and at least a portionof the folding cannula is fed through the proximal opening of thefunnel. The funnel is then locked onto the housing via the lockingmember, as shown in FIG. 7 when the user places the locking member inthe locking position or downward position, as shown by arrow BB.

In some embodiments, the funnel is configured to be unlocked/releasedfrom the bone material dispensing device by the user in vivo. Theunlocking/release of the funnel in vivo allows the user to remove thefolding cannula while the funnel is still attached to the bone materialdispensing device via a protrusion or a connector and without having toremove the funnel from the patient. This reduction in potential traumaor damage to soft tissues, particularly nerves, during funnel placementis beneficial. Unlocking/release of the funnel in vivo also reduces thenumber of steps required in a surgical procedure.

In some embodiments, the bone material dispensing device can be used inconjunction with the products found and fully described in U.S.application Ser. Nos. 15/340,770 and 15/818,395; and U.S. PublicationNos. 2017/0216051, 2018/0078385, 2017/0216045, 2018/0071113, and2016/0100955, of which are all owned by Applicant and incorporated fullyherein by reference. In some embodiments, various orthopedic implantscan be used in conjunction with the bone material dispensing device.

In some embodiments, the folding cannula can be made of a memory shapepolymer and/or alloy to allow the folding cannula to move from anunfolded configuration to a folded configuration without the need for alocking mechanism. Memory shape polymers include, but are not limited topolyethers, polyacrylates, polyamides, polysiloxanes, polyurethanes,polyethers amides, polyurethane/ureas, polyether esters, polynorborene,cross-linked polymers such as cross-linked polyethylene and cross-linkedpoly(cyclooctene), inorganic-organic hybrid polymers, and copolymerssuch as urethane/butadiene copolymers, styrene-butadiene copolymers.Memory shape alloys include, but are not limited to TiNi, CuZnAl, andFeNiAl alloys. In some embodiments, the folding cannula can befabricated by, but not be limited to, injection molding of plasticmaterials comprising rigid, surgical grade plastic and/or metalmaterials.

In some embodiments, components of the bone material dispensing systemmay be made from materials, such as for example, polyurethane, polyurea,polyether(amide), PEBA, thermoplastic elastomeric olefin, copolyester,and styrenic thermoplastic elastomer, steel, aluminum, stainless steel,titanium, nitinol, metal alloys with high non-ferrous metal content anda low relative proportion of iron, carbon fiber, glass fiber, plastics,ceramics or combinations thereof. The folding cannula, funnel portion orplunger may optionally include one or more tapered regions. In variousembodiments, these components may be blunt, beveled, diamond point, balltip, trocar tip, etc. These components may also have a tip style vitalfor accurate treatment of the patient depending on the surgical site.Examples of tip styles include, for example, Trephine, Cournand, Veress,Huber, Seldinger, Chiba, Francine, Bias, Crawford, deflected tips,Hustead, Lancet, or Tuohey. In some embodiments, the bone materialdispensing device and tray can be made from materials that allow thebone material dispensing device to be reusable, or alternatively madefrom materials that allow for a single, disposable use.

In some embodiments, the shape of the folding cannula may be selectedfor particular applications. Such shape and configuration may include,for example, the basic shape of a folding cannula (e.g., a tubularshaped cannula).

Methods

A method of dispensing a bone material is provided. The method comprisesloading a bone material dispensing device with the bone material, thebone material dispensing device comprising a housing having a framecomprising an opening configured to slidably receive at least a portionof a plunger, a locking member pivotably connected to the housing, thelocking member comprising a locking surface extending adjacent to thehousing configured to engage a surface of a funnel, the frame comprisinga contact surface and a front opening configured to engage a funnel;engaging a connector of the funnel with the front opening of the frameand the locking member being movable in a locking position, such as adownward position to lock the surface of the funnel to the housing,aligning the funnel with the frame and the funnel configured to receiveat least a portion of the plunger to dispense the bone material.

In some embodiments, the method comprises loading a bone materialdispensing device via loading the bone material into a cannula,inserting the loaded cannula into a funnel, connecting the funnel to thebone material dispensing device, locking the funnel to the bone materialdispensing device, pushing a plunger of the bone material dispensingdevice into the funnel such that the bone material exits out of thefunnel into a target site. In some embodiments, the bone material isloaded into the funnel directly without a cannula. In some embodiments,the method of implanting bone material comprises adding the bonematerial into the funnel and/or a cannula. In some embodiments, thefunnel is connected to the bone material dispensing device prior to thecannula being inserted into the funnel. In some embodiments, the plungermay receive resistance from the bone material, the funnel and/or thecannula during the operation. A remediate operation is conducted in suchscenario.

In some embodiments, the bone material dispensing device can be employedto unlock the funnel but still remains attached to the funnel and thecannula is removed and replaced with another loaded cannula. In someembodiments, a pusher is inserted into the funnel to push the bonematerial out of the funnel. In some embodiments, the bone materialdispensing device is removed from the funnel completely and a pusher isinserted into the funnel to push the bone material out of the funnel. Insome embodiments, the funnel is configured to be unlocked from the bonematerial dispensing device by the user. In some embodiments, the funnelis placed onto a holder. When placing the funnel onto a holder, the topcontact surface and the bottom contact surface of the funnel are placedto contact the contact surface of the holder. The contact surface of theholder is a depression from the holder's perimeter such that the depthsecures the funnel in place. In operation, the proximal opening of thefunnel is aligned with the second opening of the holder and theconnector of the funnel is aligned to fit into the first opening of theholder. Once the proximal portion of the funnel is secured to the holderin an upright position such that the distal portion of the funnel isfacing upward. The pusher is inserted into the funnel from the distalportion of the funnel and it is configured to push the bone material outof the proximal opening of the funnel and the second opening of theholder onto a surface. A new cannula can be placed into the funnel andthe funnel can be reattached and locked with the bone materialdispensing device to continue the delivery.

In some embodiments, the bone material can be dispensed in aquantifiable, controlled and predefined amount of from about 0.25 cc toabout 1 cc. The bone material may be dispensed in a quantifiable,controlled and predefined amount of from about 0.25, 0.30, 0.35, 0.40,0.45, 0.50, 0.55, 0.60, 0.65, 0.70, 0.75, 0.80, 0.85, 0.90, 0.95 toabout 1 cc. In some embodiments, the bone material can be dispensed in aquantifiable, controlled and predefined amount of from about 0.25 oz toabout 1 oz. The bone material may be dispensed in a quantifiable,controlled and predefined amount of from about 0.25, 0.30, 0.35, 0.40,0.45, 0.50, 0.55, 0.60, 0.65, 0.70, 0.75, 0.80, 0.85, 0.90, 0.95 toabout 1 oz.

The bone material can be mixed with liquid material and optionally atherapeutic agent until a desired consistency of the bone material isachieved (e.g., putty, paste, etc.). The bone material can be mixed witha suitable diluent and then loaded. The folding cannula may have enoughspace to allow for the bone material and a volume of diluent to bemixed. In some embodiments, the diluent includes dextrose, other sugarsincluding but not limited to, sucrose, fructose, glucose, lactatedringer's, polyols including, but not limited to, mannitol, xylitol,sorbitol, maltitol, lactitol, polysaccharides including but not limitedto native or pre-gelatinized starch, maltodextrins, cyclodextrins,mineral compounds including, but not limited to, dicalcium or tricalciumphosphate, either dihydrate or anhydrous, cellulose derivativesincluding, but not limited to, microcrystalline cellulose, lactose,either monohydrates thereof or anhydrous, as well as their mixtures suchas dicalcium phosphate dihydrate, mannitol, pre-gelatinized maizestarch, microcrystalline cellulose and their mixtures, water and/or NaCl(saline). In some embodiments, the saline is 0.90% saline or 0.45%saline. In some embodiments, other delivery vehicles can be used forexample, D5W (dextrose in 5% water), D5NS (dextrose in 5% water andnormal saline) and D5W/1/2NS (D5W and ½ normal saline), blood,mesenchymal stem cells, or the like.

The fourth compartment may include a container for holding the bonematerial and/or a vial for holding any other instruments needed for thedelivery. A fifth compartment may include gloves, drapes, wounddressings and other procedural supplies for maintaining sterility of theimplanting process, as well as an instruction booklet, which may includea chart that shows how to administer the bone material after mixing it.A sixth compartment may include the spatula, needles, additional devicesand/or sutures. Each tool may be separately packaged in a plastic pouchthat is sterilized. A seventh compartment may include an agent forradiographic imaging. A cover of the kit may include illustrations ofthe dispensing/administering procedure and a clear plastic cover may beplaced over the compartments to maintain sterility.

In various embodiments, one or more components of the bone materialdispensing system is sterilized by radiation in a terminal sterilizationstep in the final packaging. Terminal sterilization of a productprovides greater assurance of sterility than from processes such as anaseptic process, which require individual product components to besterilized separately and the final package assembled in a sterileenvironment.

In various embodiments, gamma radiation is used in the terminalsterilization step, which involves utilizing ionizing energy from gammarays that penetrate deeply into the bone material dispensing device.Gamma rays are highly effective in killing microorganisms, they leave noresidues, nor do they have sufficient energy to impart radioactivity tothe apparatus. Gamma rays can be employed when the device is in thepackage and gamma sterilization does not require high pressures orvacuum conditions, thus, package seals and other components are notstressed. In addition, gamma radiation eliminates the need for permeablepackaging materials.

In various embodiments, electron beam (e-beam) radiation may be used tosterilize one or more components of the bone material dispensing device.E-beam radiation comprises a form of ionizing energy, which is generallycharacterized by low penetration and high-dose rates. E-beam irradiationis similar to gamma processing in that it alters various chemical andmolecular bonds on contact, including the reproductive cells ofmicroorganisms. Beams produced for e-beam sterilization areconcentrated, highly-charged streams of electrons generated by theacceleration and conversion of electricity.

Other methods may also be used to sterilize the bone material dispensingsystem including, but not limited to, gas sterilization such as, forexample, with ethylene oxide or steam sterilization.

The bone material dispensing system can be used to treat a variety ofconditions including osteoporosis, bone fracture repair or healing,dental procedures for which increased bone formation in the jaw is ofclinical benefit, repair of craniofacial bone defects induced by traumaor congenital defects such as cleft palate/lip, and a number of othermusculoskeletal disorders where native bone growth is inadequate, whichwill be evident to those of ordinary skill in the art. The bone materialcan be administered to treat open fractures and fractures at high riskof non-union, and in subjects with spinal disorders, including subjectsin need of spinal fusion (e.g., anterior lumbar interbody fusion,posterior lumbar spinal fusion, and cervical spine fusion) or subjectshaving degenerative disc disease or arthritis affecting the lumbar andcervical spine.

Bone Material

In some embodiments, the bone material can be demineralized bonematerial. The demineralized bone material can comprise demineralizedbone, powder, chips, granules, shards, fibers or other shapes havingirregular or random geometries. These can include, for example,substantially demineralized, partially demineralized, or fullydemineralized cortical and cancellous bone. These also include surfacedemineralization, where the surface of the bone construct issubstantially demineralized, partially demineralized, or fullydemineralized, yet the body of the bone construct is fully mineralized.The configuration of the bone material can be obtained by milling,shaving, cutting or machining whole bone as described in, for example,U.S. Pat. No. 5,899,939. The entire disclosure is herein incorporated byreference into the present disclosure.

In some embodiments, the bone material can comprise elongateddemineralized bone fibers having an average length to average thicknessratio or aspect ratio of the fibers from about 50:1 to about 1000:1. Inoverall appearance the elongated demineralized bone fibers can be round,spherical, granular, elongated, powders, chips, fibers, cylinders,threads, narrow strips, thin sheets, or a combination thereof. In someembodiments, the bone material comprises elongated demineralized bonefibers and chips. In some embodiments, the bone material comprises fullydemineralized fibers and surface demineralized chips. In someembodiments, the ratio of fibers to chips or powders is from about 5,10, 15, 20, 25, 30, 35, 40, or 45 fibers to about 30, 35, 40, 45, 50,55, 60, 65, or 70 chips.

In some embodiments, the bone material comprises demineralized bonematrix fibers and demineralized bone matrix chips in a 30:60 ratio. Insome embodiments, the bone material comprises demineralized bone matrixfibers and demineralized bone matrix chips in a ratio of 25:75 to about75:25 fibers to chips.

In some embodiments, the bone material can be an inorganic material,such as an inorganic ceramic and/or bone substitute material. Exemplaryinorganic materials or bone substitute materials include but are notlimited to aragonite, dahlite, calcite, brushite, amorphous calciumcarbonate, vaterite, weddellite, whewellite, struvite, urate,ferrihydrate, francolite, monohydrocalcite, magnetite, goethite, dentin,calcium carbonate, calcium sulfate, calcium phosphosilicate, sodiumphosphate, calcium aluminate, calcium phosphate, hydroxyapatite,alpha-tricalcium phosphate, dicalcium phosphate, β-tricalcium phosphate,tetracalcium phosphate, amorphous calcium phosphate, octacalciumphosphate, BIOGLASS™ fluoroapatite, chlorapatite, magnesium-substitutedtricalcium phosphate, carbonate hydroxyapatite, substituted forms ofhydroxyapatite (e.g., hydroxyapatite derived from bone may besubstituted with other ions such as fluoride, chloride, magnesiumsodium, potassium, etc.), or combinations or derivatives thereof.

In some embodiments, the bone material can comprise mineral particles,which comprise tricalcium phosphate and hydroxyapatite in a ratio ofabout 80:20 to about 90:10. In some embodiments, the mineral particlescan comprise tricalcium phosphate and hydroxyapatite in a ratio of about70:30 to about 95:5. In some embodiments, the mineral particles cancomprise tricalcium phosphate and hydroxyapatite in a ratio of about85:15.

In some embodiments, the bone material may be seeded with harvested bonecells and/or bone tissue, such as for example, cortical bone, autogenousbone, allogenic bones and/or xenogeneic bone while it is mixed.

In some embodiments, the bone material may be mixed with one or moretherapeutic agents, for example, an anti-inflammatory agent, ananalgesic agent, an osteoinductive growth factor, an antimicrobial agentor a combination thereof. Osteoinductive agents include one or moremembers of the family of Bone Morphogenetic Proteins (“BMPs”). BMPs area class of proteins thought to have osteoinductive or growth-promotingactivities on endogenous bone tissue, or function as pro-collagenprecursors. Known members of the BMP family include, but are not limitedto, BMP-1, BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, BMP-8, BMP-9,BMP-10, BMP-11, BMP-12, BMP-13, BMP-14 (GDF-5), BMP-15, BMP-16, BMP-17,BMP-18 as well as polynucleotides or polypeptides thereof, as well asmature polypeptides or polynucleotides encoding the same.

BMPs utilized as osteoinductive agents comprise one or more of BMP-1;BMP-2; BMP-3; BMP-4; BMP-5; BMP-6; BMP-7; BMP-8; BMP-9; BMP-10; BMP-11;BMP-12; BMP-13; BMP-15; BMP-16; BMP-17; or BMP-18; as well as anycombination of one or more of these BMPs, including full length BMPs orfragments thereof, or combinations thereof, either as polypeptides orpolynucleotides encoding the polypeptide fragments of all of the recitedBMPs. The isolated BMP osteoinductive agents may be administered aspolynucleotides, polypeptides, full length protein or combinationsthereof.

Indeed, the osteoinductive factors are the recombinant human bonemorphogenetic proteins (rhBMPs) because they are available in unlimitedsupply and do not transmit infectious diseases. In some embodiments, thebone morphogenetic protein is a rhBMP-2, rhBMP-4, rhBMP-7, orheterodimers thereof. Recombinant BMP-2 can be used at a concentrationof about 0.4 mg/mL to about 10.0 mg/mL, preferably about 1.5 mg/mL.

The bone material may include or be mixed with one or more members fromthe TGF-β superfamily. For example, the matrix may include AMH, ARTN,GDF1, GDF10, GDF11, GDF15, GDF2, GDF3, GDF3A, GDF5, GDF6, GDF7, GDF8,GDF9, GDNF, INHA, INHBA, INHBB, INHBC, INHBE, LEFTY1, LEFTY2, MSTN,NODAL, NRTN, PSPN, TGFB1, TGFB2, TGFB3, FGF, basic FGF, VEGF,insulin-like growth factor, EGF, PDGF, nerve growth factor orcombinations thereof.

The bone material may include or be mixed with a therapeutic agentincluding, but not limited to, IL-1 inhibitors, such Kineret®(anakinra), which is a recombinant, non-glycosylated form of the humaninterleukin-1 receptor antagonist (IL-1Ra), or AMG 108, which is amonoclonal antibody that blocks the action of IL-1. The bone materialmay include or be mixed with therapeutic agents including excitatoryamino acids such as glutamate and aspartate, antagonists or inhibitorsof glutamate binding to NMDA receptors, AMPA receptors, and/or kainatereceptors. The bone material may include or be mixed with therapeuticagents to reduce inflammation including but not limited to interleukin-1receptor antagonists, thalidomide (a TNF-α release inhibitor),thalidomide analogues (which reduce TNF-α production by macrophages),quinapril (an inhibitor of angiotensin II, which upregulates TNF-α),interferons such as IL-11 (which modulate TNF-α receptor expression), oraurin-tricarboxylic acid (which inhibits TNF-α).

The bone material may include or be mixed with a therapeutic agentincluding, but not limited to, an analgesic agent. Examples of analgesicagents include, but are not limited to, acetaminophen, tramadol,lidocaine, bupivacaine, ropivacaine, opioid analgesics such asbuprenorphine, butorphanol, dextromoramide, dezocine,dextropropoxyphene, diamorphine, fentanyl, alfentanil, sufentanil,hydrocodone, hydromorphone, ketobemidone, levomethadyl, levorphanol,meperidine, methadone, morphine, nalbuphine, opium, oxycodone,papaveretum, pentazocine, pethidine, phenoperidine, piritramide,dextropropoxyphene, remifentanil, sufentanil, tilidine, tramadol,codeine, dihydrocodeine, meptazinol, dezocine, eptazocine, flupirtine ora combination thereof.

The bone material may include or be mixed with a therapeutic agentincluding, but not limited to, an anti-inflammatory agent. An example ofan anti-inflammatory agent includes, but is not limited to, clonidine,sulindac, sulfasalazine, naproxen, diclofenac, indomethacin, ibuprofen,flurbiprofen, ketoprofen, aclofenac, aloxiprin, aproxen, aspirin,diflunisal, fenoprofen, mefenamic acid, naproxen, phenylbutazone,piroxicam, meloxicam, salicylamide, salicylic acid, desoxysulindac,tenoxicam, ketoralac, clonidine, flufenisal, salsalate, triethanolaminesalicylate, aminopyrine, antipyrine, oxyphenbutazone, apazone,cintazone, flufenamic acid, clonixeril, clonixin, meclofenamic acid,flunixin, colchicine, demecolcine, allopurinol, oxypurinol, benzydaminehydrochloride, dimefadane, indoxole, intrazole, mimbane hydrochloride,paranylene hydrochloride, tetrydamine, benzindopyrine hydrochloride,fluprofen, ibufenac, naproxol, fenbufen, cinchophen, diflumidone sodium,fenamole, flutiazin, metazamide, letimide hydrochloride, nexeridinehydrochloride, octazamide, molinazole, neocinchophen, nimazole,proxazole citrate, tesicam, tesimide, tolmetin, triflumidate, fenamates(mefenamic acid, meclofenamic acid), nabumetone, celecoxib, etodolac,nimesulide, apazone, gold, tepoxalin; dithiocarbamate, or a combinationthereof.

Anti-inflammatory agents also include steroids, such as for example,21-acetoxypregnenolone, alclometasone, algestone, amcinonide,beclomethasone, betamethasone, budesonide, chloroprednisone, clobetasol,clobetasone, clocortolone, cloprednol, corticosterone, cortisone,cortivazol, deflazacort, desonide, desoximetasone, dexamethasone,dexamethasone 21-acetate, dexamethasone 21-phosphate di-Na salt,diflorasone, diflucortolone, difluprednate, enoxolone, fluazacort,flucloronide, flumethasone, flunisolide, fluocinolone acetonide,fluocinonide, fluocortin butyl, fluocortolone, fluorometholone,fluperolone acetate, fluprednidene acetate, fluprednisolone,flurandrenolide, fluticasone propionate, formocortal, halcinonide,halobetasol propionate, halometasone, halopredone acetate,hydrocortamate, hydrocortisone, loteprednol etabonate, mazipredone,medrysone, meprednisone, methylprednisolone, mometasone furoate,paramethasone, prednicarbate, prednisolone, prednisolone25-diethylamino-acetate, prednisolone sodium phosphate, prednisone,prednival, prednylidene, rimexolone, tixocortol, triamcinolone,triamcinolone acetonide, triamcinolone benetonide, triamcinolonehexacetonide or a combination thereof.

The bone material may include or be mixed with a therapeutic agentincluding, but not limited to, a statin. Examples of a useful statininclude, but are not limited to, atorvastatin, simvastatin, pravastatin,cerivastatin, mevastatin (See U.S. Pat. No. 3,883,140; the entiredisclosure is herein incorporated by reference), velostatin (also calledsynvinolin; see U.S. Pat. Nos. 4,448,784 and 4,450,171; these entiredisclosures are herein incorporated by reference), fluvastatin,lovastatin, rosuvastatin and fluindostatin (Sandoz XU-62-320),dalvastain (EP Application Publication No. 738510 A2, the entiredisclosure is herein incorporated by reference), eptastatin,pitavastatin, or pharmaceutically acceptable salts thereof or acombination thereof. In various embodiments, the statin may comprisemixtures of (+)R and (−)-S enantiomers of the statin. In variousembodiments, the statin may comprise a 1:1 racemic mixture of thestatin.

In some embodiments, the bone material can include an antimicrobialagent. In some embodiments, the antimicrobial agent can include one ormore of triclosan, also known as 2,4,4′-trichloro-2′-hydroxydiphenylether, chlorhexidine and its salts, including chlorhexidine acetate,chlorhexidine gluconate, chlorhexidine hydrochloride, and chlorhexidinesulfate, silver and its salts, including silver acetate, silverbenzoate, silver carbonate, silver citrate, silver iodate, silveriodide, silver lactate, silver laurate, silver nitrate, silver oxide,silver palmitate, silver protein, and silver sulfadiazine, polymyxin,tetracycline, aminoglycosides, such as tobramycin and gentamicin,rifampicin, bacitracin, neomycin, chloramphenicol, miconazole,quinolones such as oxolinic acid, norfloxacin, nalidixic acid,pefloxacin, enoxacin and ciprofloxacin, penicillins such as oxacillinand pipracil, nonoxynol-9, fusidic acid, cephalosporins, or combinationsthereof.

Examples of antimicrobial agents include, by way of illustration and notlimited to, acedapsone; acetosulfone sodium; alamecin; alexidine;amdinocillin; amdinocillin pivoxil; amicycline; amifloxacin; amifloxacinmesylate; amikacin; amikacin sulfate; aminosalicylic acid;aminosalicylate sodium; amoxicillin; amphomycin; ampicillin; ampicillinsodium; apalcillin sodium; apramycin; aspartocin; astromicin sulfate;avilamycin; avoparcin; azithromycin; azlocillin; azlocillin sodium;bacampicillin hydrochloride; bacitracin; bacitracin methylenedisalicylate; bacitracin zinc; bambermycins; benzoylpas calcium;berythromycin; betamicin sulfate; biapenem; biniramycin; biphenaminehydrochloride; bispyrithione magsulfex; butikacin; butirosin sulfate;capreomycin sulfate; carbadox; carbenicillin disodium; carbenicillinindanyl sodium; carbenicillin phenyl sodium; carbenicillin potassium;carumonam sodium; cefaclor; cefadroxil; cefamandole; cefamandole nafate;cefamandole sodium; cefaparole; cefatrizine; cefazaflur sodium;cefazolin; cefazolin sodium; cefbuperazone; cefdinir; cefepime; cefepimehydrochloride; cefetecol; cefixime; cefmenoxime hydrochloride;cefmetazole; cefmetazole sodium; cefonicid monosodium; cefonicid sodium;cefoperazone sodium; ceforanide; cefotaxime sodium; cefotetan; cefotetandisodium; cefotiam hydrochloride; cefoxitin; cefoxitin sodium;cefpimizole; cefpimizole sodium; cefpiramide; cefpiramide sodium;cefpirome sulfate; cefpodoxime proxetil; cefprozil; cefroxadine;cefsulodin sodium; ceftazidime; ceftibuten; ceftizoxime sodium;ceftriaxone sodium; cefuroxime; cefuroxime axetil; cefuroxime pivoxetil;cefuroxime sodium; cephacetrile sodium; cephalexin; cephalexinhydrochloride; cephaloglycin; cephaloridine; cephalothin sodium;cephapirin sodium; cephradine; cetocycline hydrochloride; cetophenicol;chloramphenicol; chloramphenicol palmitate; chloramphenicol pantothenatecomplex; chloramphenicol sodium succinate; chlorhexidine phosphanilate;chloroxylenol; chlortetracycline bisulfate; chlortetracyclinehydrochloride; cinoxacin; ciprofloxacin; ciprofloxacin hydrochloride;cirolemycin; clarithromycin; clinafloxacin hydrochloride; clindamycin;clindamycin hydrochloride; clindamycin palmitate hydrochloride;clindamycin phosphate; clofazimine; cloxacillin benzathine; cloxacillinsodium; chlorhexidine, cloxyquin; colistimethate sodium; colistinsulfate; coumermycin; coumermycin sodium; cyclacillin; cycloserine;dalfopristin; dapsone; daptomycin; demeclocycline; demeclocyclinehydrochloride; demecycline; denofungin; diaveridine; dicloxacillin;dicloxacillin sodium; dihydrostreptomycin sulfate; dipyrithione;dirithromycin; doxycycline; doxycycline calcium; doxycycline fosfatex;doxycycline hyclate; droxacin sodium; enoxacin; epicillin;epitetracycline hydrochloride; erythromycin; erythromycin acistrate;erythromycin estolate; erythromycin ethylsuccinate; erythromycingluceptate; erythromycin lactobionate; erythromycin propionate;erythromycin stearate; ethambutol hydrochloride; ethionamide;fleroxacin; floxacillin; fludalanine; flumequine; fosfomycin; fosfomycintromethamine; fumoxicillin; furazolium chloride; furazolium tartrate;fusidate sodium; fusidic acid; ganciclovir and ganciclovir sodium;gentamicin sulfate; gloximonam; gramicidin; haloprogin; hetacillin;hetacillin potassium; hexedine; ibafloxacin; imipenem; isoconazole;isepamicin; isoniazid; josamycin; kanamycin sulfate; kitasamycin;levofuraltadone; levopropylcillin potassium; lexithromycin; lincomycin;lincomycin hydrochloride; lomefloxacin; lomefloxacin hydrochloride;lomefloxacin mesylate; loracarbef; mafenide; meclocycline; meclocyclinesulfosalicylate; megalomicin potassium phosphate; mequidox; meropenem;methacycline; methacycline hydrochloride; methenamine; methenaminehippurate; methenamine mandelate; methicillin sodium; metioprim;metronidazole hydrochloride; metronidazole phosphate; mezlocillin;mezlocillin sodium; minocycline; minocycline hydrochloride; mirincamycinhydrochloride; monensin; monensin sodiumr; nafcillin sodium; nalidixatesodium; nalidixic acid; natainycin; nebramycin; neomycin palmitate;neomycin sulfate; neomycin undecylenate; netilmicin sulfate;neutramycin; nifuiradene; nifuraldezone; nifuratel; nifuratrone;nifurdazil; nifurimide; nifiupirinol; nifurquinazol; nifurthiazole;nitrocycline; nitrofurantoin; nitromide; norfloxacin; novobiocin sodium;ofloxacin; onnetoprim; oxacillin and oxacillin sodium; oximonam;oximonam sodium; oxolinic acid; oxytetracycline; oxytetracyclinecalcium; oxytetracycline hydrochloride; paldimycin; parachlorophenol;paulomycin; pefloxacin; pefloxacin mesylate; penamecillin; penicillinssuch as penicillin g benzathine, penicillin g potassium, penicillin gprocaine, penicillin g sodium, penicillin v, penicillin v benzathine,penicillin v hydrabamine, and penicillin v potassium; pentizidonesodium; phenyl aminosalicylate; piperacillin sodium; pirbenicillinsodium; piridicillin sodium; pirlimycin hydrochloride; pivampicillinhydrochloride; pivampicillin pamoate; pivampicillin probenate; polymyxinb sulfate; porfiromycin; propikacin; pyrazinamide; pyrithione zinc;quindecamine acetate; quinupristin; racephenicol; ramoplanin; ranimycin;relomycin; repromicin; rifabutin; rifametane; rifamexil; rifamide;rifampin; rifapentine; rifaximin; rolitetracycline; rolitetracyclinenitrate; rosaramicin; rosaramicin butyrate; rosaramicin propionate;rosaramicin sodium phosphate; rosaramicin stearate; rosoxacin;roxarsone; roxithromycin; sancycline; sanfetrinem sodium; sarmoxicillin;sarpicillin; scopafungin; sisomicin; sisomicin sulfate; sparfloxacin;spectinomycin hydrochloride; spiramycin; stallimycin hydrochloride;steffimycin; streptomycin sulfate; streptonicozid; sulfabenz;sulfabenzamide; sulfacetamide; sulfacetamide sodium; sulfacytine;sulfadiazine; sulfadiazine sodium; sulfadoxine; sulfalene;sulfamerazine; sulfameter; sulfamethazine; sulfamethizole;sulfamethoxazole; sulfamonomethoxine; sulfamoxole; sulfanilate zinc;sulfanitran; sulfasalazine; sulfasomizole; sulfathiazole; sulfazamet;sulfisoxazole; sulfisoxazole acetyl; sulfisboxazole diolamine;sulfomyxin; sulopenem; sultamricillin; suncillin sodium; talampicillinhydrochloride; teicoplanin; temafloxacin hydrochloride; temocillin;tetracycline; tetracycline hydrochloride; tetracycline phosphatecomplex; tetroxoprim; thiamphenicol; thiphencillin potassium;ticarcillin cresyl sodium; ticarcillin disodium; ticarcillin monosodium;ticlatone; tiodonium chloride; tobramycin; tobramycin sulfate; tosufloxacin; trimethoprim; trimethoprim sulfate; trisulfapyrimidines;troleandomycin; trospectomycin sulfate; tyrothricin; vancomycin;vancomycin hydrochloride; virginiamycin; zorbamycin; or combinationsthereof.

The antimicrobial agent in the bone material can be an antiviral agentthat can be mixed with the bone material. Antiviral agents can include,but are not limited to, vidarabine, acyclovir, famciclovir,valacyclovir, gancyclovir, valganciclovir, nucleoside-analog reversetranscriptase inhibitors (such as AZT (zidovudine), ddI (didanosine),ddC (zalcitabine), d4T (stavudine), and 3TC (lamivudine)), nevirapine,delavirdine, protease inhibitors (such as, saquinavir, ritonavir,indinavir, and nelfinavir), ribavirin, amantadine, rimantadine,neuraminidase inhibitors (such as zanamivir and oseltamivir),pleconaril, cidofovir, foscarnet, and/or interferons.

Although the invention has been described with reference to embodiments,persons skilled in the art will recognize that changes may be made inform and detail without departing from the spirit and scope of thedisclosure.

What is claimed is:
 1. A bone material dispensing system comprising afunnel having a proximal portion, the proximal portion comprising a topend and a bottom end, the top end opposite the bottom end, the top endcomprising a surface having a protrusion configured to receive a lockingmember of a bone material dispensing device and the bottom endcomprising a connector configured to secure the funnel to the bonematerial dispensing device.
 2. The bone material dispensing system ofclaim 1, wherein the protrusion comprises two protrusions dispose on twoopposite ends of the surface of the top end across a width of theproximal portion.
 3. The bone material dispensing system of claim 2,wherein the two protrusions define the boundary of the locking membersuch that the two protrusions stabilize the locking member.
 4. The bonematerial dispensing system of claim 1, wherein the surface comprises acrescent shape pointing upward toward the locking member.
 5. The bonematerial dispensing system of claim 1, wherein the protrusion extendsalong a direction transverse to a central axis of the funnel.
 6. Thebone material dispensing system of claim 1, wherein the bottom endcomprises a first tapered edge and a second tapered edge joining at anapex.
 7. The bone material dispensing system of claim 6, wherein theconnector of the bottom end is adjacent to the apex.
 8. The bonematerial dispensing system of claim 1, wherein the connector of thebottom end extends along a central axis of the funnel.
 9. The bonematerial dispensing system of claim 1, when the connector secures thefunnel to the bone material dispensing device, the connector becomes apivot point such that the funnel is configured to rotate about theconnector.
 10. The bone material dispensing system of claim 1, whereinthe proximal portion comprises a body disposed between the top end andthe bottom end, the body having an opening configured to receive acannula and/or a plunger.
 11. The bone material dispensing system ofclaim 10, wherein the cannula comprises a folding cannula.
 12. The bonematerial dispensing system of claim 11, wherein the folding cannula hasa diameter smaller than a diameter of the opening of the funnel so as toallow at least a portion of the folding cannula to be held within thefunnel.
 13. The bone material dispensing system of claim 1, wherein thefunnel comprises a funnel body adjacent to the proximal portion of thefunnel.
 14. The bone material dispensing system of claim 13, wherein thefunnel body has a proximal end and a distal end, the proximal end anddistal end each having a diameter, the diameter of the proximal endbeing larger than the diameter of the distal end.
 15. The bone materialdispensing system of claim 14, wherein the proximal end has a generallyconical shape having an inner surface and a decreasing diameter towardthe funnel body.
 16. The bone material dispensing system of claim 14,wherein an inner surface of the distal end comprises a ring of ledgeconfigured to retain a folding cannula.
 17. A bone material dispensingsystem comprising a funnel having a proximal portion, the proximalportion comprising a top end and a bottom end, the top end opposite thebottom end, the top end comprising a surface having a protrusionconfigured to receive a locking member of a bone material dispensingdevice and the bottom end comprising a connector configured to securethe funnel to the bone material dispensing device; a pusher having ashaft and a head, the shaft having a diameter smaller than a diameter ofthe funnel body and at least a portion of the pusher configured toslidably move within the funnel; and a holder configured to receive theproximal portion of the funnel.
 18. The bone material dispensing systemof claim 17, wherein the holder comprises a contact surface having anopening configured to secure the connector of the funnel.
 19. A methodof dispensing a bone material, the method comprising loading bonematerial into a bone material dispensing system, the bone materialdispensing system comprising a funnel having a proximal portion, theproximal portion comprising a top end and a bottom end, the top endopposite the bottom end, the top end comprising a surface having aprotrusion configured to receive a locking member of a bone materialdispensing device and the bottom end comprising a connector configuredto secure the funnel to the bone material dispensing device.
 20. Themethod of dispensing bone material of claim 19, the method furthercomprising inserting a pusher into the funnel to dispense remaining bonematerial from the funnel.